-The Economic Times A new book by Bibek Debroy on Gujarat looks at how this much-talked about state has performed in economic terms. The author argues history, luck and administrative clarity have been the determining factors. There has been a discernible pickup in Gujarat's growth performance since the 10th Plan (2002-07), the five-year Plans being natural periods for breaking up the timeline. It's tempting to argue that there is nothing exceptional in...
More »SEARCH RESULT
Total Matching Records found : 273
Govt to bring essential medicines under price control -Kounteya Sinha
-The Times of India India will, for the first time, put a cap on the maximum price at which essential drugs, like some commonly used anti-AIDS and anti-cancer drugs, besides a horde of painkillers, anti-TB drugs, sedatives, lipid lowering agents and steroids, can be sold in the country. In a landmark decision, a group of ministers (GoM) headed by agriculture minister Sharad Pawar on Thursday cleared the proposal to bring all 348...
More »Soon, drugs may become cheaper -Rupali Mukherjee
-The Times of India MUMBAI: Consumers can look forward to a reduction in prices of essential medicines, with the Sharad Pawar-led Group of Ministers (GoM) planning to take a final decision on the pharmaceutical policy soon. The GoM will meet on September 27 to examine options under the market price-based mechanism to cap prices of drugs, which may lead to a reduction ranging from 25% to even 90% in some cases,...
More »Cipla wins patent case over Tarceva -CH Unnikrishnan
-Live Mint Cipla Ltd won a landmark patent case against Swiss drug maker F Hoffmann-La Roche Ltd in the Delhi high court on Friday over the Indian company’s generic copy of lung cancer drug Tarceva after a four-year court battle. Justice Manmohan Singh observed in his 280-page judgement that it had been scientifically proven that Cipla’s generic version was a polymorph B variant of Roche’s patented drug and that it didn’t actually...
More »Curb on over-the-counter sale of 92 antibiotics soon -Kounteya Sinha
-The Times of India Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules. Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription. The drugs will also have to carry a prominent label in red...
More »
